![Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer | BMC Cancer Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer | BMC Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-07186-5/MediaObjects/12885_2020_7186_Fig4_HTML.png)
Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer | BMC Cancer
![Serosal surfaces, mucin pools, and deposits, Oh my: challenges in staging colorectal carcinoma | Modern Pathology Serosal surfaces, mucin pools, and deposits, Oh my: challenges in staging colorectal carcinoma | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmodpathol.2014.128/MediaObjects/41379_2015_Article_BFmodpathol2014128_Fig1_HTML.jpg)
Serosal surfaces, mucin pools, and deposits, Oh my: challenges in staging colorectal carcinoma | Modern Pathology
![Rectal cancer lexicon 2023 revised and updated consensus statement from the Society of Abdominal Radiology Colorectal and Anal Cancer Disease-Focused Panel | Abdominal Radiology Rectal cancer lexicon 2023 revised and updated consensus statement from the Society of Abdominal Radiology Colorectal and Anal Cancer Disease-Focused Panel | Abdominal Radiology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00261-023-03893-2/MediaObjects/261_2023_3893_Figa_HTML.png)
Rectal cancer lexicon 2023 revised and updated consensus statement from the Society of Abdominal Radiology Colorectal and Anal Cancer Disease-Focused Panel | Abdominal Radiology
![Molecular characterization of colorectal adenomas with and without malignancy reveals distinguishing genome, transcriptome and methylome alterations | Scientific Reports Molecular characterization of colorectal adenomas with and without malignancy reveals distinguishing genome, transcriptome and methylome alterations | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-018-21525-4/MediaObjects/41598_2018_21525_Fig1_HTML.jpg)
Molecular characterization of colorectal adenomas with and without malignancy reveals distinguishing genome, transcriptome and methylome alterations | Scientific Reports
![Connection and distinction of tumor regression grading systems of gastrointestinal cancer - ScienceDirect Connection and distinction of tumor regression grading systems of gastrointestinal cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0344033820306968-gr4.jpg)
Connection and distinction of tumor regression grading systems of gastrointestinal cancer - ScienceDirect
Protocol for the Examination of Resection Specimens From Patients With Primary Carcinoma of the Colon and Rectum
Protocol for the Examination of Resection Specimens From Patients With Primary Carcinoma of the Colon and Rectum
![HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria | Journal of Cancer Research and Clinical Oncology HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria | Journal of Cancer Research and Clinical Oncology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00432-022-04230-8/MediaObjects/432_2022_4230_Fig1_HTML.png)
HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria | Journal of Cancer Research and Clinical Oncology
![Frontiers | Colon Sparing Endoscopic Full-Thickness Resection for Advanced Colorectal Lesions: Is It Time for Global Adoption? Frontiers | Colon Sparing Endoscopic Full-Thickness Resection for Advanced Colorectal Lesions: Is It Time for Global Adoption?](https://www.frontiersin.org/files/Articles/967100/fonc-12-967100-HTML-r1/image_m/fonc-12-967100-g001.jpg)